Drs. Mavragani and Moutsopoulos reply

REFERENCES

1. 1.↵
   1. Killian M,
   2. Batteux F,
   3. Paul S

   . The MRL/lpr mouse model: an important animal model for systemic Sjögren syndrome and polyautoimmunity. J Rheumatol 2020;47:157.

   OpenUrlFREE Full Text
2. 2.↵
   1. Mavragani CP,
   2. Moutsopoulos HM

   . Primary versus secondary Sjögren syndrome: is it time to reconsider these terms? J Rheumatol 2019;46:665–6.

   OpenUrlFREE Full Text
3. 3.↵
   1. Watanabe-Fukunaga R,
   2. Brannan CI,
   3. Copeland NG,
   4. Jenkins NA,
   5. Nagata S

   . Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314–7.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Lavoie TN,
   2. Lee BH,
   3. Nguyen CQ

   . Current concepts: mouse models of Sjögren’s syndrome. J Biomed Biotechnol 2011;2011:549107.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Moutsopoulos HM,
   2. Balow JE,
   3. Lawley TJ,
   4. Stahl NI,
   5. Antonovych TT,
   6. Chused TM

   . Immune complex glomerulonephritis in sicca syndrome. Am J Med 1978;64:955–60.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Goules AV,
   2. Tatouli IP,
   3. Moutsopoulos HM,
   4. Tzioufas AG

   . Clinically significant renal involvement in primary Sjögren’s syndrome: clinical presentation and outcome. Arthritis Rheum 2013;65:2945–53.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Pavlakis PP,
   2. Alexopoulos H,
   3. Kosmidis ML,
   4. Mamali I,
   5. Moutsopoulos HM,
   6. Tzioufas AG,
   7. et al.

   Peripheral neuropathies in Sjögren’s syndrome: a critical update on clinical features and pathogenetic mechanisms. J Autoimmun 2012;39:27–33.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Skopouli FN,
   2. Dafni U,
   3. Ioannidis JP,
   4. Moutsopoulos HM

   . Clinical evolution, and morbidity and mortality of primary Sjögren’s syndrome. Semin Arthritis Rheum 2000;29:296–304.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Fragkioudaki S,
   2. Mavragani CP,
   3. Moutsopoulos HM

   . Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use. Medicine 2016;95:e3766.

   OpenUrl
10. 10.↵
    1. Mavragani CP,
    2. Moutsopoulos HM

    . Conventional therapy of Sjogren’s syndrome. Clin Rev Allergy Immunol 2007;32:284–91.

    OpenUrlCrossRefPubMed